Effect of collimator choice on quantitative assessment of cardiac iodine 123 MIBG uptake

Journal of Nuclear Cardiology

Volumn 10, Issue 6, 2003, Pages 623-632

  Inoue, Yusuke ^a   Suzuki, Akira ^b   Shirouzu, Ichiro ^b   Machida, Toru ^b   Yoshizawa, Yasunori ^b   Akita, Fumihide ^b   Ohnishi, Satoshi ^b   Yoshikawa, Kohki ^a   Ohtomo, Kuni ^c  

^a UNIVERSITY OF TOKYO   (Japan)

^b Kanto Teishin Hospital   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Collimator; Iodine 123 metaiodobenzylguanidine; Quantitation; Septal penetration

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123;

ARTICLE; COLLIMATOR; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DRUG UPTAKE; GEOMETRY; HEART; HEART NERVE; HEART SCINTISCANNING; IMAGE PROCESSING; IMAGE QUALITY; LIVER FUNCTION; LUNG FUNCTION; MEDIASTINUM; NERVE FUNCTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RELIABILITY; SYMPATHETIC NERVE; TISSUE DISTRIBUTION;

EID: 0346401195     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-3581(03)00652-4     Document Type: Article

References (17)

1. Patel AD, Iskandrian AE. MIBG imaging. J Nucl Cardiol 2002;9: 75-94.
2. Hattori N, Schwaiger M. Metaiodobenzylguanidine scintigraphy of the heart: what have we learnt clinically? Eur J Nucl Med 2000;27:1-6.
3. 123I-labelled compounds in clinical practice. Eur J Nucl Med 1999;26:655-8.
4. Macey DJ, DeNardo GL, DeNardo SJ, Hines HH. Comparison of low- and medium-energy collimators for SPECT imaging with iodine-123-labeled antibodies. J Nucl Med 1986;27:1467-74.
5. De Geeter FD, Franken PR, Defrise M, et al. Optimal collimator choice for sequential iodine-123 and technetium-99m imaging. Eur J Nucl Med 1996;23:768-74.
6. Ichihara T, Ogawa K, Motomura N, Kubo A, Hashimoto S. Compton scatter compensation using the triple-energy window method for single- and dual-isotope SPECT. J Nucl Med 1993;34: 2216-21.
7. Gilland DR, Jaszczak RJ, Turkington TG, Greer KL, Coleman RE. Volume and activity quantitation with iodine-123 SPECT. J Nucl Med 1994;35:1707-13.
8. Ogasawara K, Hashimoto J, Ogawa K, et al. Simultaneous acquisition of iodine-123 emission and technetium-99m transmission data for quantitative brain single-photon emission tomographic imaging. Eur J Nucl Med 1998;25:1537-44.
9. Ogawa K. Simulation study of triple-energy-window scatter correction in combined Tl-201, Tc-99m SPECT. Ann Nucl Med 1994;8:277-81.
10. Buvat I, Benali H, Todd-Pokropek A, Di Paola R. Scatter correction in scintigraphy: the state of art. Eur J Nucl Med 1994;21:675-94.
11. Saito K, Takeda K, Okamoto S, et al. Detection of doxorubicin cardiotoxicity by using iodine-123 BMIPP early dynamic SPECT: quantitative evaluation of early abnormality of fatty acid metabolism with the Rutland method. J Nucl Cardiol 2000;7:553-61.
12. Kim Y, Sawada Y, Fujiwara G, Chiba H, Nishimura T. Therapeutic effect of co-enzyme Q10 on idiopathic dilated cardiomyopathy: assessment by iodine-123 labelled 15-(p-iodophenyl)-3(R,S)-methylpentadecanoic acid myocardial single-photon emission tomography. Eur J Nucl Med 1997;24:629-34.
13. Takeda K, Saito K, Makino K, et al. Iodine- 123-BMIPP myocardial washout and cardiac work during exercise in normal and ischemic hearts. J Nucl Med 1997;38:559-63.
14. 201Tl cardiac SPECT. IEEE Trans Nucl Sci 1997;44:2465-72.
15. Narita Y, Iida H. Scatter correction in myocardial thallium SPECT: needs for optimization of energy window settings in the energy window-based scatter correction techniques [in Japanese]. Kaku Igaku 1999;36:83-90.
16. Iida H, Narita Y, Kado H, et al. Effects of scatter and attenuation correction on quantitative assessment of regional cerebral blood flow with SPECT. J Nucl Med 1998;39:181-9.
17. Hashimoto J, Sasaki T, Ogawa K, et al. Effects of scatter and attenuation correction on quantitative analysis of β-CIT brain SPET. Nucl Med Commun 1999;20:159-65.